Daniel J Crona (Daniel Crona)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Journal of the American Geriatrics Society

Pharmacogenomics

The pharmacogenomics journal

Cancer research

University of North Carolina

University of North Carolina System (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina Oct 01 2015

United States

Assistant Professor :: Pharmacotherapy and Experimental Therapeutics

Education History

University of North Carolina System

United States

PHD :: Pharmacotherapy and Experimental Therapeutics

University of Colorado Denver

United States

BSC :: Biology

Publications

C Adrian Austin, Keia Sanderson, Daniel J Crona, Christine E Kistler
Pharmacogenetics: Using science to reduce racial bias in pain management? Journal of the American Geriatrics Society (2023)
Christine E Kistler, Charles Adrian Austin, Junjian J Liu, Madison Cauble, Andrew Wise, Sheel M Patel, Kimberly Ward, Tim Wiltshire, Fei Zou, Andy H Szeto, Daniel J Crona
The feasibility and potential of pharmacogenetics to reduce adverse drug events in nursing home residents. Journal of the American Geriatrics Society 70 (5) (2022)
Lindsay Ratner, Jing 'Daisy' Zhu, Megan N Gower, Tejendra Patel, Jordan A Miller, Amber Cipriani, George A Stouffer, Daniel J Crona, And Craig R Lee
Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patients. Pharmacogenomics 23 (3) (2022)
Julia Coelho França Quintanilha, Alessandro Racioppi, Jin Wang, Amy S Etheridge, Stefanie Denning, Carol E Peña, Andrew D Skol, Daniel J Crona, Danyu Lin, Federico Innocenti
PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors. The pharmacogenomics journal (2021)
Stephanie I Kim, Andy H Szeto, Katherine P Morgan, Blaine Brower, Mary W Dunn, Amir H Khandani, Paul A Godley, Tracy L Rose, Ethan M Basch, Matthew I Milowsky, Young E Whang, Daniel J Crona
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer. PloS one 16 (6) (2021)
Jing 'Daisy' Zhu, Yi Shuan Shirley Wu, Ryan J Beechinor, Ryan M Kemper, Laura H Bukkems, Ron A A Mathot, Marjon H Cnossen, Daniel Gonzalez, Sheh-Li Chen, Nigel S Key, Daniel J Crona
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Andy H Szeto, Tyler Bucci, Allison Deal, Anqi Zhu, Majd Ahmad, Amanda S Cass, Margaret R Sketch, Ryan Kemper, Joshua F Zeidner, Matthew C Foster, Benyam Muluneh, Daniel J Crona
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia. The Annals of pharmacotherapy (2021)
Andreas S Kalogirou, Michael P East, Tuomo Laitinen, Chad D Torrice, Kaitlyn A Maffuid, David Harold Drewry, Panayiotis A Koutentis, Gary L Johnson, Daniel J Crona, Christopher R M Asquith
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors. Molecules (Basel, Switzerland) 26 (19) (2021)
Jing Zhu, Tejendra Patel, Jordan A Miller, Chad D Torrice, Mehak Aggarwal, Margaret R Sketch, Maurice D Alexander, Paul M Armistead, James M Coghill, Tatjana Grgic, Katarzyna J Jamieson, Jonathan R Ptachcinski, Marcie L Riches, Jonathan S Serody, John L Schmitz, J Ryan Shaw, Thomas C Shea, Oscar Suzuki, Benjamin G Vincent, William A Wood, Kamakshi V Rao, Tim Wiltshire, Eric T Weimer, Daniel J Crona
Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients. International journal of molecular sciences 21 (3) (2020)
Jing 'Daisy' Zhu, Amy L Pasternak, Daniel J Crona
The future of research into genetics and the precision dosing of tacrolimus: what do we need to know? Pharmacogenomics 21 (15) (2020)
Sarah E Stump, Young E Whang, Daniel J Crona
Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints. Investigational new drugs 36 (6) (2018)
Daniel J Crona, Andrew D Skol, Veli-Matti Leppänen, Dylan M Glubb, Amy S Etheridge, Eleanor Hilliard, Carol E Peña, Yuri K Peterson, Nancy Klauber-DeMore, Kari K Alitalo, Federico Innocenti
Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib. Cancer research 79 (1) (2018)

Daniel J Crona.css-eqlu8i{font-size:small;padding-left:4px;} (Daniel Crona)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel J Crona (Daniel Crona)